We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter Est. Return
-14.06%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.24B
AUM Growth
-$98.1M
(-7.4%)
Cap. Flow
+$139M
Cap. Flow % of AUM
Cap. Flow %
11.27%
Top 10 Holdings %
Top 10 Hldgs %
39.9%
Holding
2,819
New
365
Increased
978
Reduced
847
Closed
217
Avg Time Held
Equity + Options
2.1
years
Top 10 Avg Time Held
Equity + Options
1.3
years
Top 20 Avg Time Held
Equity + Options
1.5
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVB Financial
CVBF
|
+$78.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$48.7M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$16.1M |
| 4 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$10.8M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$8.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$13.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.79M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.79M |
| 4 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$6.62M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 54.43% |
| 2 | Technology | 12.95% |
| 3 | Financials | 11.18% |
| 4 | Healthcare | 5.67% |
| 5 | Consumer Discretionary | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Cytosorbents Corp
CTSO
$13M
| $1K | ﹤0.01% |
11
| – | – |
2019 Q4
1 quarter
|
|
2252
CVR Energy
CVI
$6.17B
| $1K | ﹤0.01% |
+64
| New | +$1.93K |
2020 Q1
0 quarters
|
|
2253
Endava
DAVA
$109M
| $1K | ﹤0.01% |
+29
| New | +$1.32K |
2020 Q1
0 quarters
|
|
2254
Dillards
DDS
$10.4B
| $1K | ﹤0.01% |
37
-141
| -79% | -$8.24K |
2017 Q1
12 quarters
|
|
2255
DoubleLine Income Solutions Fund
DSL
$1.12B
| $1K | ﹤0.01% |
91
| – | – |
2017 Q1
12 quarters
|
|
2256
BlackRock Debt Strategies Fund
DSU
$560M
| $1K | ﹤0.01% |
152
+3
| +2% | +$31 |
2018 Q1
8 quarters
|
|
2257
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.71B
| $1K | ﹤0.01% |
87
-1,451
| -94% | -$37.8K |
2019 Q2
3 quarters
|
|
2258
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.02B
| $1K | ﹤0.01% |
214
-1,102
| -84% | -$10.3K |
2018 Q2
7 quarters
|
|
2259
Evercore
EVR
$9.8B
| $1K | ﹤0.01% |
23
-172
| -88% | -$11.5K |
2018 Q2
7 quarters
|
|
2260
iShares MSCI Mexico ETF
EWW
$1.48B
| $1K | ﹤0.01% |
52
-1,990
| -97% | -$83K |
2019 Q4
1 quarter
|
|
2261
Extreme Networks
EXTR
$2.87B
| $1K | ﹤0.01% |
421
| – | – |
2018 Q4
5 quarters
|
|
2262
DELISTED
Flushing Financial
FFIC
| $1K | ﹤0.01% |
+117
| New | +$2.15K |
2020 Q1
0 quarters
|
|
2263
Kyntra Bio
KYNB
$19.6M
| $1K | ﹤0.01% |
1
-2
| -67% | -$1.99K |
2019 Q2
3 quarters
|
|
2264
National Beverage
FIZZ
$3.27B
| $1K | ﹤0.01% |
72
| – | – |
2016 Q4
13 quarters
|
|
2265
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.28B
| $1K | ﹤0.01% |
29
| – | – |
2017 Q3
10 quarters
|
|
2266
Gladstone Investment Corp
GAIN
$599M
| $1K | ﹤0.01% |
+150
| New | +$1.78K |
2020 Q1
0 quarters
|
|
2267
The Greenbrier Companies
GBX
$1.21B
| $1K | ﹤0.01% |
+105
| New | +$2.49K |
2020 Q1
0 quarters
|
|
2268
Green Dot
GDOT
$695M
| $1K | ﹤0.01% |
62
-10
| -14% | -$288 |
2019 Q2
3 quarters
|
|
2269
Greif
GEF
$4.67B
| $1K | ﹤0.01% |
+59
| New | +$2.24K |
2020 Q1
0 quarters
|
|
2270
iShares US & Intl High Yield Corp Bond ETF
GHYG
$186M
| $1K | ﹤0.01% |
42
| – | – |
2016 Q4
13 quarters
|
|
2271
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
| $1K | ﹤0.01% |
+6
| New | +$1.29K |
2020 Q1
0 quarters
|
|
2272
Acushnet Holdings
GOLF
$4.69B
| $1K | ﹤0.01% |
72
| – | – |
2019 Q4
1 quarter
|
|
2273
Hanmi Financial
HAFC
$923M
| $1K | ﹤0.01% |
103
-102
| -50% | -$1.63K |
2018 Q4
5 quarters
|
|
2274
HUTCHMED
HCM
$2.44B
| $1K | ﹤0.01% |
78
-1,665
| -96% | -$40.2K |
2019 Q3
2 quarters
|
|
2275
Hilton Grand Vacations
HGV
$2.75B
| $1K | ﹤0.01% |
109
+53
| +95% | +$1.46K |
2017 Q1
12 quarters
|
|
Similar funds
Parallel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Parallel Advisors held 2,819 positions worth $1.24B, down 7.4% from $1.33B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Parallel Advisors deployed $139M of net new capital in Q1 2020, opening 365 new positions and adding to 978 existing holdings. Its largest new stake was Adverum Biotechnologies: 5,766 shares worth $563K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 59% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $13.1M trimmed.
- Parallel Advisors's largest Q1 2020 buy was Adverum Biotechnologies: 5,766 shares worth $563K.
- Parallel Advisors added most to CVB Financial in Q1 2020, an estimated $78.5M increase.
- Parallel Advisors's biggest Q1 2020 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $13.1M.
- Parallel Advisors fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q1 2020, selling an estimated $1.38M.
- Parallel Advisors's ten largest holdings make up 40% of its $1.24B portfolio in Q1 2020.
- Parallel Advisors opened 365 new positions and closed 217 in Q1 2020.
- Parallel Advisors's portfolio value fell 7.4% quarter-over-quarter to $1.24B.
Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.